its being manipulated right here. The platform will be used with other drugs now. Plant ZMapp will get an order ........... They will produce many different drug. NLNK and cow. ZMapp animal and plant. TKMR is plant also. I just bought at 1.89.................... I could hate myself tomorrow.
he may make me rich when this takes off. I am into my retirement money now. I think Amgen or SGK will buy them. Amgen is producing the animal ZMAPP and SGK in a a collaboration with us.
3.5 to 2 dollars then a good run up 2 to 2.7 and back to 2 dollars. I think press will be getting a handle on what IBIO has and how Plantibodies is a disruptive technology. GAME changing new cost for drugs will be worth investing in. BIOTECH stocks have been a hit for two years. This is a stock of the year play.
Wait for the GATES screwing the big Pharmacy press. Then their will be the press AMGEN writes billions off of unused equipment to make animal antibodies. THEN drugs getting 90% cheaper because of Billionaire donors. The press will get a hold of whats going on.
The wat Robert Erwin put it any plant based ZMapp made and it uses our technology/license/royalties. I have the interview to prove it. Ibio About To Help Mass Produce Ebola Drug ZMapp
By Ciaran Thornton
Oct 6, 2014 8:45:45 AM PDT IBIO- Robert Erwin, President of Ibio stated "iBio and Caliber announced a Licence and collaboration on February 19, 2013. That Agreement is ongoing." you were lied to by Seeking Alpha. I would tell the author about it. They SUK
I just purchased 17000 more tonight. I averaged the heck down. when the press reads GATES sticks it the pharmacy companies we will make money. Either SGK/Caliber get the contract or they don't. I feel they want the same drug as the doctor got and got better to speed up the treatments. That's plant ZMapp and we make money. I could see the pharma companies buy these plant antibody companies. SEEKING Alpha had a different agenda and lied to the world. The truth will come out.
its about many big pharma drugs that Gates can make very cheap. Estimates are for one tenth. The shorts will be brutal. I am buying all the way down.
How would you feel if 1/2 your portfolio was Amgen and biotech companies. Amgen is in direct competition making an mammal cell ZMapp. This platform is worth a lot of money and costing them hundreds of millions. They will stop at nothing. That's just one company. The rest are looking at a huge hit on popular drugs. How would you to invest in Amgen in the beginning. MY dad has told me that story a dozen times.
Its big pharma money that are getting killed by these new plant antibodies. They have a hit line up that can be duplicated. PILLS could get 90% cheaper for generics. GSK is or shot and I hope they are upfront with our platforms that increase accuracy, cost, consistency, homogeneity, informatics, gene and Clonal Expression ........... its all about genes passing information to make antibodies the same every time. You just Infect the Tabaco, and Extract the antibodies. IBIO specialize in increasing the right information ,consistence, and quality, quantity doing it right. GATES is on our side,
GSK tap caliber collaboration .... Galaxo and Caliber/RJ Reynolds/IBIO is collaborating and One of the three, run by Texas A&M Health Science Center in partnership with Britain's GlaxoSmithKline Plc, This would be good for IBIO. What every body don't see is Amgen wants in using old techniques they paid hundreds of thousands of dollars for. The Animal cell methods. GATES money is shaking up cheap vaccines and medicine. I expect to see headlines of these new Plantibodies being produced for 1/10 the cost of big Pharma. Big Pharma will go down swinging as some of their equipment is not needed. That could explain the stupid shorts and shorting. VIVA GATES!!!!!!!!!!!!!!!! The pharmacies just pass cost to the drugs and shareholders.
US health officials have asked three advanced biology laboratories to submit plans for producing the experimental Ebola drug ZMapp .. Biomedical Advanced Research and Development Authority (BARDA) will evaluate proposals- Once proposals are submitted on 10 November, BARDA would then select one or more of the labs to start producing ZMapp, which is currently manufactured in tobacco plants by Kentucky Bioprocessing, a unit of Reynolds American Inc. Texas has teamed up with Caliber Biotherapeutics of Bryan, Texas, on tobacco plant-based manufacturing. One state-of-the-art manufacturing centre in Texas will submit plans for manufacturing ZMapp, said Dr Brett Giroir, chief executive officer of Texas A&M Health Science Center, which houses the lab. The lab works in conjunction with Britain’s GlaxoSmithKline Plc. The two other US emergency drug manufacturing centres are a facility led by Emergent Biosolutions in Baltimore and a second in Holly Springs, North Carolina, led by Swiss drug company Novartis AG. Representatives of those two labs were not immediately available for comment.
These shorts are creative. You have to give that to them. I have to laugh as the interview with Robert Erin was were they got the information about the three manufacturing companies. Then the Alpha Beotch said IBIO didn't have any thing to do with ZMapp. Then the contract was no good with Caliber Biotherapeutics. JUST because they do sloppy DD does not mean we don't take notes.
does that mean your short was covered? Good call as this could double with one press from Robert